The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Contemporary use of inpatient antineoplastic (IP) treatment (Rx): Who is getting care and why?
 
Hilal Hachem
No Relationships to Disclose
 
David Levitz
No Relationships to Disclose
 
Danai Dima
No Relationships to Disclose
 
Joshua R. Dower
No Relationships to Disclose
 
Rabiah B. Fresco
No Relationships to Disclose
 
Ruth Ann Weidner
No Relationships to Disclose
 
Rachel J. Buchsbaum
Patents, Royalties, Other Intellectual Property - “Potent Agelastatin Derivatives as Modulators for Cancer Invasion and Metastasis” Provisional patent application: Docket Number: MITX-9505/00US 317239-2690 5/13/2017 application in collaboration with Dr. Mohammad Movassaghi (Inst)
 
John Kalil Erban
Stock and Other Ownership Interests - Merck; Merck (I); Perrigo; Perrigo (I); Prothena; Prothena (I)
Consulting or Advisory Role - Tesaro
Research Funding - Macrogenics (Inst); Tesaro (Inst)
 
Susan K. Parsons
Research Funding - Seagen (Inst)